Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 4—April 2004
Dispatch

West Nile Virus, Guadeloupe

René Quirin*, Michel Salas†, Stéphan Zientara‡, Hervé Zeller§, Jacques Labie‡, Séverine Murri§, Thierry Lefrançois*, Martial Petitclerc†, and Dominique Martinez*Comments to Author 
Author affiliations: *Centre de Coopération Internationale en Recherche Agronomique pour le Développement, Petit Bourg, Guadeloupe, French West Indies; †Direction des Services Vétérinaires de Guadeloupe, Basse Terre, Guadeloupe, French West Indies; ‡Agence Française de Sécurité Sanitaire des Aliments, Maison Alfort, France; and §Institut Pasteur, Lyon, France

Main Article

Table 1

West Nile virus IgGa antibody prevalence in horses in seven equine centers, Guadeloupe and Marie Galante, July 2002–January 2003

Place No. tested July 2002 Positive Prevalence % No. tested Jan 2003 Positive Prevalence % Seroconversion rate %
A
 25
 1
 4.0
 23
 14
 60.9
 59.1
B
 51
 2
 3.9
 44
 27
 61.4
 59.5
C
 7
 2
 28.6
 7
 5
 71.4
 60.0
D
 13
 5
 38.5
 12
 7
 58.3
 28.5
E
10b
 2
 20.0
F
2b
 2
 100.0
G
 4
 0
 0.0
 5
 3
 60.0
 60.0
H
 7
 0
 0.0
 9
 3
 33.3
 33.3
I
 6
 0
 0.0
 24
 5
 20.8
 20.8
Total 113 10 8.8 136 68 50.0

     aIgG, immunoglobulin G.
     bImported after July 2002.

Main Article

Page created: February 09, 2011
Page updated: February 09, 2011
Page reviewed: February 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external